Compare fund portfolios
See how two funds' portfolios overlap. Enter two tickers:
TMED vs PHLAX
Shared holdings
21
TMED covered by PHLAX
38.27%
PHLAX covered by TMED
38.27%
Coverage = share of one portfolio's weight reproduced by the other (overlapping positions, min weight). Top 50 positions per side shown; = held by both — hover a shared position to highlight it in both columns.
TMED (March 31, 2026)
| Security | Weight | |
|---|---|---|
| LILLY ELI and CO | 14.43% | |
| UNITEDHEALTH GRP | 6.52% | |
| THERMO FISHER SCIENTIFIC INC | 4.58% | |
| GILEAD SCIENCES INC | 4.13% | |
| ABBOTT LABS | 3.90% | |
| DANAHER CORP | 2.72% | |
| MEDTRONIC PLC | 2.24% | |
| ALNYLAM PHARMACEUTICALS INC | 2.05% | |
| STRYKER CORP | 2.00% | |
| DYNE THERAPEUTICS INC | 1.87% | |
| WATERS CORP | 1.75% | |
| BECTON DICKINSON and CO | 1.70% | |
| AGILENT TECHNOLOGIES INC | 1.68% | |
| ELANCO ANIMAL HEALTH INC | 1.58% | |
| HUMANA INC | 1.56% | |
| CYTOKINETICS INC | 1.53% | |
| WEST PHARMACEUTICAL SVCS INC | 1.48% | |
| BOSTON SCIENTIFIC CORP | 1.46% | |
| Ascendis Pharma A/S | 1.39% | |
| BIOGEN INC | 1.25% | |
| VAXCYTE INC | 1.18% | |
| IMMUNOME INC | 1.15% | |
| METTLER-TOLEDO INTL INC | 1.10% | |
| CENCORA INC | 1.06% | |
| APELLIS PHARMACEUTICALS INC | 1.02% | |
| REGENERON PHARMACEUTICALS INC | 1.01% | |
| DEXCOM INC | 1.00% | |
| CVS HEALTH CORP | 0.95% | |
| MOONLAKE IMMUNOTHERAPEUTICS | 0.89% | |
| INSULET CORP | 0.83% | |
| ADAPTIVE BIOTECHNOLOGIES CORP | 0.82% | |
| BICARA THERAPEUTICS INC | 0.81% | |
| BIONTECH SE ADR | 0.80% | |
| IMMATICS NV COMMON STOCK | 0.79% | |
| REPLIGEN CORP | 0.79% | |
| COOPER COS INC | 0.77% | |
| SHATTUCK LABS INC | 0.76% | |
| IDEXX LABS INC | 0.74% | |
| XENON PHARMACEUTICALS INC | 0.73% | |
| SAREPTA THERAPEUTICS INC | 0.73% | |
| BRISTOL-MYERS SQUIBB CO | 0.73% | |
| MOLINA HEALTHCARE INC | 0.71% | |
| APOGEE THERAPEUTICS INC | 0.69% | |
| CG ONCOLOGY INC | 0.68% | |
| AGIOS PHARMACEUTICALS INC | 0.65% | |
| INCYTE CORP | 0.65% | |
| KYMERA THERAPEUTICS INC | 0.61% | |
| OPTION | 0.58% | |
| CABALETTA BIO INC | 0.58% | |
| ALIGN TECHNOLOGY INC | 0.53% |
PHLAX (Feb. 27, 2026)
| Security | Weight | |
|---|---|---|
| LILLY ELI and CO | 16.46% | |
| (PIPA070) PGIM Core Government Money Market Fund | 7.57% | |
| MERCK & CO | 5.90% | |
| GILEAD SCIENCES INC | 4.29% | |
| UNITEDHEALTH GRP | 4.23% | |
| VERTEX PHARMACEUTICALS INC | 3.49% | |
| CVS HEALTH CORP | 3.21% | |
| LONZA GROUP -REG | 3.07% | |
| ARGENX SE SPONSORED ADR | 3.05% | |
| REGENERON PHARMACEUTICALS INC | 3.01% | |
| DANAHER CORP | 2.99% | |
| THERMO FISHER SCIENTIFIC INC | 2.74% | |
| ROIVANT SCIENCES LTD | 1.99% | |
| VAXCYTE INC | 1.92% | |
| TEVA PHARMACEUTICAL IND ADR | 1.90% | |
| BEONE MEDICINES LTD ADR | 1.87% | |
| PALVELLA THERAPEUTICS INC | 1.66% | |
| AGILENT TECHNOLOGIES INC | 1.66% | |
| SIONNA THERAPEUTICS INC | 1.60% | |
| SCHOLAR ROCK HOLDING CORP | 1.56% | |
| PRUDENTIAL INVESTMENT PORTFOLIOS 2 PRUDENTIAL INSTITUTIONA 0.00000000 | 1.55% | |
| EDWARDS LIFESCIENCES CORP | 1.53% | |
| XENON PHARMACEUTICALS INC | 1.52% | |
| INSMED INC | 1.34% | |
| KYMERA THERAPEUTICS INC | 1.33% | |
| NEWAMSTERDAM PHARMA COMPANY NV | 1.27% | |
| APOGEE THERAPEUTICS INC | 1.13% | |
| ASTRAZENECA PLC | 1.11% | |
| Bayer Aktiengesellschaft | 1.02% | |
| CRINETICS PHARMACEUTICALS INC | 0.99% | |
| VIRIDIAN THERAPEUTICS INC | 0.91% | |
| DISC MEDICINE INC | 0.89% | |
| TANDEM DIABETES CARE INC | 0.84% | |
| APELLIS PHARMACEUTICALS INC | 0.84% | |
| PROTAGONIST THERAPEUTICS INC | 0.84% | |
| TARSUS PHARMACEUTICALS INC | 0.83% | |
| MINERALYS THERAPEUTICS INC | 0.79% | |
| CABALETTA BIO INC | 0.79% | |
| ALIGN TECHNOLOGY INC | 0.78% | |
| UCB SA | 0.74% | |
| ARCUTIS BIOTHERAPEUTICS INC | 0.71% | |
| REVOLUTION MEDICINES INC | 0.66% | |
| OLEMA PHARMACEUTICALS INC | 0.56% | |
| CELCUITY INC | 0.55% | |
| IMMUNOVANT INC | 0.52% | |
| TYRA BIOSCIENCES INC | 0.41% | |
| LB PHARMACEUTICALS INC | 0.37% | |
| Abivax SA SPONSORED ADS | 0.37% | |
| COMPASS Pathways PLC, ADR | 0.28% | |
| UNIQURE N.V. | 0.24% |
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.